2020 annual financial data
ResMed 2020 Operating income growth
Direct answer
Operating income growth was 39.77%.
Operating income was 809,659,000 USD and net income was 621,674,000 USD.
Operating cash flow was 802,255,000 USD.
Get free ResMed email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,957,013,000 USD
- Operating income
- 809,659,000 USD
- Net income
- 621,674,000 USD
- Operating cash flow
- 802,255,000 USD